INVA 241220 12.50C (INVA241220C12500) Stock Options, News & Quotes

US OptionsDetailed Quotes

INVA241220C12500

Watchlist

3.70
0.000.00%

15min DelayClose Nov 27 16:00 ET

0.00High0.00Low

Intraday

5D
Daily

News

Innoviva to Participate in the Citi 2024 Global Healthcare Conference
BusinesswireNov 26 07:00 ET
Innoviva Reports Strong Q3 Growth Amidst Strategic Advances
TipRanksNov 19 22:54 ET
Innoviva to Participate in the UBS Global Healthcare Conference
InnovivaNov 12 00:00 ET
Innoviva, Inc.'s (NASDAQ:INVA) Business Is Yet to Catch Up With Its Share Price
Simply Wall StNov 9 07:01 ET
Innoviva GAAP EPS of $0.02, Revenue of $89.51M Beats by $12.59M
Seeking AlphaNov 7 02:37 ET
Innoviva Reports Q3 EPS 2c, Two Estimates 26c
TipRanksNov 6 16:39 ET

Comments

Moomoo AI

Dec 10, 2023 06:29

Innoviva presents inefficiencies in capital allocation, given its low ROE and stunting earnings growth despite retaining all profits. Comparatively poorer performance to industry's 8.5% growth raises doubts about their reinvestment strategies. Caution advised due to its risk landscape.

Innoviva, Inc. (NASDAQ:INVA) Is Going Strong But Fundamentals Appear To Be Mixed : Is There A Clear Direction For The Stock?

Moomoo AI

Nov 19, 2023 06:37

Recent insider stock sale at Innoviva prompts concern given the timing and scale. The lack of insider ownership paired with their readiness to sell at current prices suggests no urgency to buy shares.

This Insider Has Just Sold Shares In Innoviva